FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104778830> ?p ?o ?g. }

• W2104778830 endingPage "34" @default.
• W2104778830 startingPage "29" @default.
• W2104778830 abstract "The three main aims of treatment for paroxysmal atrial fibrillation are: (1) to suppress paroxysms of atrial fibrillation and maintain long-term sinus rhythm; (2) to control heart rate during paroxysms of atrial fibrillation if they occur; and (3) to prevent the complications associated with paroxysmal atrial fibrillation—that is, stroke and tachycardia-induced cardiomyopathy.1Many patients with paroxysmal atrial fibrillation can be highly symptomatic, although asymptomatic paroxysms are common.2 However, the abolition of symptoms of paroxysmal atrial fibrillation does not necessarily mean abolition of the atrial fibrillation per se, as heart rate slowing may abolish symptoms but still allow asymptomatic episodes to continue.3 In some patients, it may be appropriate to document the frequency of arrhythmia by Holter monitoring or event recording. Of note, most pharmacological studies of paroxysmal atrial fibrillation have concentrated on the reduction of symptomatic recurrences of paroxysmal atrial fibrillation.If attacks of paroxysmal atrial fibrillation are frequent, current clinical practice usually uses chronic prophylaxis with drugs to reduce the frequency of paroxysms after removal of precipitating factors such as caffeine, alcohol, stress, and adequate treatment of underlying diseases such as myocardial ischaemia, thyrotoxicosis, and heart failure.1In the long term, few patients achieve complete suppression of paroxysms of atrial fibrillation. Drug treatment for paroxysmal atrial fibrillation may be administered as prophylaxis against recurrent atrial fibrillation, but in those patients who are asymptomatic or have rare paroxysms (eg, only a few paroxysms a year) may decide not to take routine medication or to use a “pill-in-the-pocket” strategy, and the patient’s views need to be considered.Based on the systematic review undertaken as part of this guideline development, propafenone appears to be at least as effective as sotalol in preventing the recurrence of atrial fibrillation for up to 12 months following administration,4,5 although for …" @default.
• W2104778830 created "2016-06-24" @default.
• W2104778830 creator A5038405190 @default.
• W2104778830 creator A5047304762 @default.
• W2104778830 creator A5016256132 @default.
• W2104778830 date "2007-01-01" @default.
• W2104778830 modified "2023-10-01" @default.
• W2104778830 title "Rhythm control and cardioversion" @default.
• W2104778830 cites W1841210729 @default.
• W2104778830 cites W1964656664 @default.
• W2104778830 cites W1964897845 @default.
• W2104778830 cites W1977757208 @default.
• W2104778830 cites W1986483440 @default.
• W2104778830 cites W1988904908 @default.
• W2104778830 cites W2003719834 @default.
• W2104778830 cites W2008138428 @default.
• W2104778830 cites W2010550566 @default.
• W2104778830 cites W2023042216 @default.
• W2104778830 cites W2025380144 @default.
• W2104778830 cites W2026137049 @default.
• W2104778830 cites W2032097349 @default.
• W2104778830 cites W2043486935 @default.
• W2104778830 cites W2045622353 @default.
• W2104778830 cites W2047488895 @default.
• W2104778830 cites W2049040735 @default.
• W2104778830 cites W2049435276 @default.
• W2104778830 cites W2052755535 @default.
• W2104778830 cites W2054167248 @default.
• W2104778830 cites W2062279066 @default.
• W2104778830 cites W2063659045 @default.
• W2104778830 cites W2076862186 @default.
• W2104778830 cites W2087685091 @default.
• W2104778830 cites W2089571277 @default.
• W2104778830 cites W2103968030 @default.
• W2104778830 cites W2108941538 @default.
• W2104778830 cites W2111002085 @default.
• W2104778830 cites W2122609241 @default.
• W2104778830 cites W2127619549 @default.
• W2104778830 cites W2135009225 @default.
• W2104778830 cites W2141499643 @default.
• W2104778830 cites W2142559425 @default.
• W2104778830 cites W2145021382 @default.
• W2104778830 cites W2145884004 @default.
• W2104778830 cites W2148188644 @default.
• W2104778830 cites W2154269490 @default.
• W2104778830 cites W2164847230 @default.
• W2104778830 cites W2166887354 @default.
• W2104778830 cites W2169189402 @default.
• W2104778830 cites W2326579808 @default.
• W2104778830 cites W2329793854 @default.
• W2104778830 cites W2413321887 @default.
• W2104778830 cites W2579362106 @default.
• W2104778830 cites W4240380219 @default.
• W2104778830 cites W4247432378 @default.
• W2104778830 cites W94193321 @default.
• W2104778830 doi "https://doi.org/10.1136/hrt.2006.099879" @default.
• W2104778830 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1861343" @default.
• W2104778830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16963490" @default.
• W2104778830 hasPublicationYear "2007" @default.
• W2104778830 type Work @default.
• W2104778830 sameAs 2104778830 @default.
• W2104778830 citedByCount "23" @default.
• W2104778830 countsByYear W21047788302012 @default.
• W2104778830 countsByYear W21047788302015 @default.
• W2104778830 countsByYear W21047788302016 @default.
• W2104778830 countsByYear W21047788302017 @default.
• W2104778830 countsByYear W21047788302018 @default.
• W2104778830 countsByYear W21047788302019 @default.
• W2104778830 countsByYear W21047788302021 @default.
• W2104778830 crossrefType "journal-article" @default.
• W2104778830 hasAuthorship W2104778830A5016256132 @default.
• W2104778830 hasAuthorship W2104778830A5038405190 @default.
• W2104778830 hasAuthorship W2104778830A5047304762 @default.
• W2104778830 hasBestOaLocation W21047788302 @default.
• W2104778830 hasConcept C126322002 @default.
• W2104778830 hasConcept C135343436 @default.
• W2104778830 hasConcept C164705383 @default.
• W2104778830 hasConcept C2777289489 @default.
• W2104778830 hasConcept C2779161974 @default.
• W2104778830 hasConcept C2780065318 @default.
• W2104778830 hasConcept C71924100 @default.
• W2104778830 hasConceptScore W2104778830C126322002 @default.
• W2104778830 hasConceptScore W2104778830C135343436 @default.
• W2104778830 hasConceptScore W2104778830C164705383 @default.
• W2104778830 hasConceptScore W2104778830C2777289489 @default.
• W2104778830 hasConceptScore W2104778830C2779161974 @default.
• W2104778830 hasConceptScore W2104778830C2780065318 @default.
• W2104778830 hasConceptScore W2104778830C71924100 @default.
• W2104778830 hasIssue "1" @default.
• W2104778830 hasLocation W21047788301 @default.
• W2104778830 hasLocation W21047788302 @default.
• W2104778830 hasLocation W21047788303 @default.
• W2104778830 hasLocation W21047788304 @default.
• W2104778830 hasOpenAccess W2104778830 @default.
• W2104778830 hasPrimaryLocation W21047788301 @default.
• W2104778830 hasRelatedWork W1972651039 @default.
• W2104778830 hasRelatedWork W1990763588 @default.
• W2104778830 hasRelatedWork W2049054851 @default.

• next